Abstract
Nanoemulsions, usually spherical, are a group of dispersed particles used for pharmaceutical and biomedical aids and vehicles that show great promise for the future of cosmetics, diagnostics, drug therapies and biotechnologies. They exist in a wide variety of forms that are dictated by the particle components. Nanoemulsions are generally considered to be in the size range of less than and around 100 nm in diameter. The particles can exist as water-in-oil and oil-inwater forms, where the core of the particle is either water or oil, respectively. More complex variations also exist but these are often larger. The longer-term properties of the particle are dependent on the composition of the adsorbed material lying at the dispersed droplet interface with the dispersion medium. This has an impact on the partitioning and extraction of droplet contents. Thermodynamically stable particles are characterized by having a very low surface tension and this produces a very large surface area. Nanoemulsions can also include small meta-stable very small-scale emulsions; here the surface properties and chemistry can strongly influence behaviour. Processing, storage and formulation composition can also have an impact on the longevity of a pharmaceutical preparation. Some revolutionary new nanoemulsion droplets based on fluorinated compounds are finding a number of widespread biomedical roles and applications. Developments in nanoemulsion technology are likely to lead to a much greater use of this medium in future pharmaceuticals.
Keywords: topicals, parenterals, encapsulation, surfactant, surface engineering, surface rheology
Current Drug Delivery
Title: Engineering of Nanoemulsions for Drug Delivery
Volume: 2 Issue: 4
Author(s): Dipak K. Sarker
Affiliation:
Keywords: topicals, parenterals, encapsulation, surfactant, surface engineering, surface rheology
Abstract: Nanoemulsions, usually spherical, are a group of dispersed particles used for pharmaceutical and biomedical aids and vehicles that show great promise for the future of cosmetics, diagnostics, drug therapies and biotechnologies. They exist in a wide variety of forms that are dictated by the particle components. Nanoemulsions are generally considered to be in the size range of less than and around 100 nm in diameter. The particles can exist as water-in-oil and oil-inwater forms, where the core of the particle is either water or oil, respectively. More complex variations also exist but these are often larger. The longer-term properties of the particle are dependent on the composition of the adsorbed material lying at the dispersed droplet interface with the dispersion medium. This has an impact on the partitioning and extraction of droplet contents. Thermodynamically stable particles are characterized by having a very low surface tension and this produces a very large surface area. Nanoemulsions can also include small meta-stable very small-scale emulsions; here the surface properties and chemistry can strongly influence behaviour. Processing, storage and formulation composition can also have an impact on the longevity of a pharmaceutical preparation. Some revolutionary new nanoemulsion droplets based on fluorinated compounds are finding a number of widespread biomedical roles and applications. Developments in nanoemulsion technology are likely to lead to a much greater use of this medium in future pharmaceuticals.
Export Options
About this article
Cite this article as:
Sarker K. Dipak, Engineering of Nanoemulsions for Drug Delivery, Current Drug Delivery 2005; 2 (4) . https://dx.doi.org/10.2174/156720105774370267
DOI https://dx.doi.org/10.2174/156720105774370267 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurotoxicity of β-Amyloid Protein: Oligomerization, Channel Formation and Calcium Dyshomeostasis
Current Pharmaceutical Design Influence of Usnic Acid and its Derivatives on the Activity of Mammalian Poly(ADP-ribose)polymerase 1 and DNA Polymerase β
Medicinal Chemistry Subject Index To Volume 1
Recent Patents on Anti-Cancer Drug Discovery The Quinolone Family: From Antibacterial to Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents The Role of Oxidative Stress in Smoking-Related Diseases
Mini-Reviews in Organic Chemistry Terpenoids and Glycolipids from Euphorbiaceae
Mini-Reviews in Medicinal Chemistry Mass Spectrometry Imaging: Applications in Drug Distribution Studies
Current Drug Metabolism Regenerative Therapies for Improving Myocardial Perfusion in Patients with Cardiovascular Disease: Failure to Meet Expectations but Optimism for the Future
Current Vascular Pharmacology Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates
Cardiovascular & Hematological Disorders-Drug Targets How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?
Current Cardiology Reviews Emerging Role of GPR30/GPER1 in Skeletal Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Direct Renin Inhibition: Promising Treatment in Renoprotection?
Recent Patents on Cardiovascular Drug Discovery Expression and Function of Bcl-2 Proteins in Melanoma
Current Genomics Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats
Current Molecular Medicine Inhibition of Molecular Signaling in Huh-7 Cells by AM3: A Novel Chemotherapeutic Agent for Hepatocellular Carcinoma
Medicinal Chemistry Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design Idronoxil as an Anticancer Agent: Activity and Mechanisms
Current Cancer Drug Targets Hematopoietic Transplants for Disease Suppression and Cure in Type 1 Diabetes
Current Stem Cell Research & Therapy An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
Current Drug Abuse Reviews Gastrointestinal Safety of Selective COX-2 Inhibitors
Current Pharmaceutical Design